Incentives for global public health : patent law and access to essential medicines / / edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein [[electronic resource]] |
Pubbl/distr/stampa | Cambridge : , : Cambridge University Press, , 2010 |
Descrizione fisica | 1 online resource (xxi, 512 pages) : digital, PDF file(s) |
Disciplina | 362.17/82 |
Collana | Connecting international law with public law |
Soggetto topico |
Pharmaceutical policy
Patent laws and legislation Drugs - Patents Patents (International law) |
ISBN |
0-511-85021-2
1-107-20320-1 1-282-72332-4 9786612723322 0-511-74929-5 0-511-74349-1 0-511-75004-8 0-511-74242-8 0-511-75078-1 0-511-74458-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Introduction: access to essential medicines: public health and international law / Thomas Pogge, Matthew Rimmer and Kim Rubenstein -- TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis / Rochelle C. Dreyfuss -- The TRIPS waiver as a recognition of public health concerns in the WTO / Andrew D. Mitchell and Tania Voon -- Public law challenges to the regulation of pharmaceutical patents in the US bilateral free trade agreements / Hitoshi Nasu -- Global health and development: patents and public interest / Elizabeth Siew Kuan Ng -- The Health Impact Fund: better pharmaceutical innovations at much lower price / Thomas Pogge -- The Health Impact Fund: a critique / Kathleen Liddell -- A prize system as a partial solution to the health crisis in the developing world / William W. Fisher and Talha Syed -- Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation / Thomas Faunce -- Opening the dam: patent pools, innovation, and access to essential medicines / Dianne Nicol and Jane Nielsen -- Open source drug discovery: a revolutionary paradigm or a Utopian model? Krishna Ravi Srinivas -- Accessing and benefit sharing avian influenza viruses through the World Health Organisation: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? / Charles Lawson and Barbara Ann Hocking -- The Lazarus effect: the (RED) campaign and creative capitalism / Matthew Rimmer -- Beyond TRIPS: the role of non-state actors and access to essential medicines / Noah Benjamin Novogrodsky -- Securing health through rights / Katharine G. Young -- The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India / Rajshree Chandra -- Tipping point: Thai compulsory licenses redefine essential medicines debate / Jonathan Burton-MacLeod. |
Record Nr. | UNINA-9910459296403321 |
Cambridge : , : Cambridge University Press, , 2010 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Incentives for global public health : patent law and access to essential medicines / / edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein [[electronic resource]] |
Pubbl/distr/stampa | Cambridge : , : Cambridge University Press, , 2010 |
Descrizione fisica | 1 online resource (xxi, 512 pages) : digital, PDF file(s) |
Disciplina | 362.17/82 |
Collana | Connecting international law with public law |
Soggetto topico |
Pharmaceutical policy
Patent laws and legislation Drugs - Patents Patents (International law) |
ISBN |
0-511-85021-2
1-107-20320-1 1-282-72332-4 9786612723322 0-511-74929-5 0-511-74349-1 0-511-75004-8 0-511-74242-8 0-511-75078-1 0-511-74458-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Introduction: access to essential medicines: public health and international law / Thomas Pogge, Matthew Rimmer and Kim Rubenstein -- TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis / Rochelle C. Dreyfuss -- The TRIPS waiver as a recognition of public health concerns in the WTO / Andrew D. Mitchell and Tania Voon -- Public law challenges to the regulation of pharmaceutical patents in the US bilateral free trade agreements / Hitoshi Nasu -- Global health and development: patents and public interest / Elizabeth Siew Kuan Ng -- The Health Impact Fund: better pharmaceutical innovations at much lower price / Thomas Pogge -- The Health Impact Fund: a critique / Kathleen Liddell -- A prize system as a partial solution to the health crisis in the developing world / William W. Fisher and Talha Syed -- Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation / Thomas Faunce -- Opening the dam: patent pools, innovation, and access to essential medicines / Dianne Nicol and Jane Nielsen -- Open source drug discovery: a revolutionary paradigm or a Utopian model? Krishna Ravi Srinivas -- Accessing and benefit sharing avian influenza viruses through the World Health Organisation: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? / Charles Lawson and Barbara Ann Hocking -- The Lazarus effect: the (RED) campaign and creative capitalism / Matthew Rimmer -- Beyond TRIPS: the role of non-state actors and access to essential medicines / Noah Benjamin Novogrodsky -- Securing health through rights / Katharine G. Young -- The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India / Rajshree Chandra -- Tipping point: Thai compulsory licenses redefine essential medicines debate / Jonathan Burton-MacLeod. |
Record Nr. | UNINA-9910784943703321 |
Cambridge : , : Cambridge University Press, , 2010 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Incentives for global public health : patent law and access to essential medicines / / edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Cambridge, : Cambridge University Press, 2010 |
Descrizione fisica | 1 online resource (xxi, 512 pages) : digital, PDF file(s) |
Disciplina | 362.17/82 |
Altri autori (Persone) |
PoggeThomas <1953->
RimmerMatthew RubensteinKim |
Collana | Connecting international law with public law |
Soggetto topico |
Pharmaceutical policy
Patent laws and legislation Drugs Patents (International law) |
ISBN |
0-511-85021-2
1-107-20320-1 1-282-72332-4 9786612723322 0-511-74929-5 0-511-74349-1 0-511-75004-8 0-511-74242-8 0-511-75078-1 0-511-74458-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Introduction: access to essential medicines: public health and international law / Thomas Pogge, Matthew Rimmer and Kim Rubenstein -- TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis / Rochelle C. Dreyfuss -- The TRIPS waiver as a recognition of public health concerns in the WTO / Andrew D. Mitchell and Tania Voon -- Public law challenges to the regulation of pharmaceutical patents in the US bilateral free trade agreements / Hitoshi Nasu -- Global health and development: patents and public interest / Elizabeth Siew Kuan Ng -- The Health Impact Fund: better pharmaceutical innovations at much lower price / Thomas Pogge -- The Health Impact Fund: a critique / Kathleen Liddell -- A prize system as a partial solution to the health crisis in the developing world / William W. Fisher and Talha Syed -- Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation / Thomas Faunce -- Opening the dam: patent pools, innovation, and access to essential medicines / Dianne Nicol and Jane Nielsen -- Open source drug discovery: a revolutionary paradigm or a Utopian model? Krishna Ravi Srinivas -- Accessing and benefit sharing avian influenza viruses through the World Health Organisation: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? / Charles Lawson and Barbara Ann Hocking -- The Lazarus effect: the (RED) campaign and creative capitalism / Matthew Rimmer -- Beyond TRIPS: the role of non-state actors and access to essential medicines / Noah Benjamin Novogrodsky -- Securing health through rights / Katharine G. Young -- The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India / Rajshree Chandra -- Tipping point: Thai compulsory licenses redefine essential medicines debate / Jonathan Burton-MacLeod. |
Record Nr. | UNINA-9910819117203321 |
Cambridge, : Cambridge University Press, 2010 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Intellectual Property and Clean Energy : The Paris Agreement and Climate Justice / / edited by Matthew Rimmer |
Edizione | [1st ed. 2018.] |
Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2018 |
Descrizione fisica | 1 online resource (686 pages) |
Disciplina | 346.048 |
Soggetto topico |
Mass media
Law International environmental law Environmental law Environmental policy Climate change IT Law, Media Law, Intellectual Property International Environmental Law Environmental Law/Policy/Ecojustice Climate Change Management and Policy |
ISBN | 981-13-2155-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Part I: International Law -- 1. The Paris Agreement: Intellectual Property, Technology Transfer and Climate Change -- 2. The Paris Agreement, Climate Finance and Transparency: Charting the Path to Equity -- 3. The Paris Agreement: Development, the North-South Divide and Human Rights -- 4. Climate Change and Human Rights: Intellectual Property Challenges and Opportunities -- Part II: Patent Law -- 5. Intergenerational Justice: a Framework for Addressing Intellectual Property Rights and Climate Change -- 6. Management of Intellectual Property in Australia's Clean Technology Sector: Challenges and Opportunities in an Uncertain Regulatory Environment -- 7. Intellectual Property, Climate Change and Technology Transfer in South Asia -- 8. Intellectual Ventures: Patent Law, Climate Change, and Geoengineering -- Part III: Trademark Law and Related Rights -- 9. Trademark Goodwill and Green Global Value Networks -- 10. This Ain’t Your Daddy’s Greenwashing: An Assessment of the American Petroleum Institute’s Power Past Impossible Campaign -- 11. The Power of Visual Appeal: Designs Law and Clean Energy -- 12. Key Change: The Role of the Creative Industries in Climate Change Action -- Part IV: Privacy and Trade Secrets -- 13. Environmental Sousveillance, Citizen Science and Smart Grids -- 14. Promoting and Protecting Clean Energy Innovation Through The Trade Secrets Regime: Issues and Implications -- Part V: Open Innovation -- 15. Energy Democracy, Renewables and the Paris Agreement -- 16. Change Change and Open Data: Information Environmentalism -- 17. Open Government Data in an Age of Growing Hostility Towards Science -- 18. Elon Musk’s Open Innovation: Tesla, Intellectual Property, and Climate Change -- Part VI: Plant Breeders’ Rights, Food Security, Access to Genetic Resources, and Indigenous Knowledge -- 19. Path-breaking or history-repeating? Analysing the Paris Agreement’s research and development paradigm for climate-smart agriculture -- 20. Genetic resources, intellectual property and climate change -- 21. Benefit Sharing Under the REDD+ Mechanisms: Implications for Women -- 22. Northern Exposure: Climate Change, Indigenous Rights, and Atmospheric Trust Litigation in Alaska. |
Record Nr. | UNINA-9910300055403321 |
Singapore : , : Springer Singapore : , : Imprint : Springer, , 2018 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|